Status:
COMPLETED
Kazakh Version of Reflux Symptom Index
Lead Sponsor:
Kazakh Medical University of Continuing Education
Collaborating Sponsors:
Asfendiyarov Kazakh National Medical University
Conditions:
Laryngopharyngeal Reflux Symptoms
Laryngopharyngitis Chronic
Eligibility:
All Genders
18-74 years
Brief Summary
Reflux symptoms index (RSI) were developed to identify a clinical index of suspicion for laryngopharyngeal reflux (LPR) in patients with ear, nose, and throat symptoms. RSI is an efficient diagnostic ...
Eligibility Criteria
Inclusion
- Patient's informed consent;
- Age: 18-74 years old;
- No serious somatic diseases;
- Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching;
- Diagnosis: Chronic pharyngitis;
- Chronic laryngitis.
Exclusion
- Disagreement to participate in scientific research;
- Age: under 18 and over 74;
- Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs;
- Patients with pulmonary pathologies;
- Patients with allergic manifestations (chronic or allergic rhinosinusitis and nasal polyposis);
- With diagnoses: Acute respiratory diseases;
- Patients with general neuralgic disorders;
- Pregnancy;
- Benign lesions of the vocal cords;
- Acid-suppressive therapy within 4 weeks prior to recruitment
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 16 2022
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT05296655
Start Date
March 1 2020
End Date
February 16 2022
Last Update
May 23 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
SOS Medical Assistance
Almaty, Kazakhstan
2
V-ent
Almaty, Kazakhstan